Analysis of mutation types and frequencies in patient-derived cancer samples deposited in the cBio Cancer Genomics Portal (cbioportal.org; accessed on 8 February 2022) database revealed that Rb1 is altered (point mutations, deletion, amplification) in 7% of all samples. The gene discussed is RB1; the disease is cancer.